14,484 reports of this reaction
9.5% of all HYDROCODONE BITARTRATE AND ACETAMINOPHEN reports
#2 most reported adverse reaction
OVERDOSE is the #2 most commonly reported adverse reaction for HYDROCODONE BITARTRATE AND ACETAMINOPHEN, manufactured by Amneal Pharmaceuticals LLC. There are 14,484 FDA adverse event reports linking HYDROCODONE BITARTRATE AND ACETAMINOPHEN to OVERDOSE. This represents approximately 9.5% of all 153,212 adverse event reports for this drug.
Patients taking HYDROCODONE BITARTRATE AND ACETAMINOPHEN who experience overdose should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OVERDOSE is moderately reported among HYDROCODONE BITARTRATE AND ACETAMINOPHEN users, representing a notable but not dominant share of adverse events.
In addition to overdose, the following adverse reactions have been reported for HYDROCODONE BITARTRATE AND ACETAMINOPHEN:
The following drugs have also been linked to overdose in FDA adverse event reports:
OVERDOSE has been reported as an adverse event in 14,484 FDA reports for HYDROCODONE BITARTRATE AND ACETAMINOPHEN. This does not prove causation, but indicates an association observed in post-market surveillance data.
OVERDOSE accounts for approximately 9.5% of all adverse event reports for HYDROCODONE BITARTRATE AND ACETAMINOPHEN, making it one of the most commonly reported side effect.
If you experience overdose while taking HYDROCODONE BITARTRATE AND ACETAMINOPHEN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.